Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …

Background N7-methylguanosine (m7G) is one of the most common RNA posttranscriptional
modifications; however, its potential role in hepatocellular carcinoma (HCC) remains …

Background Hepatocellular carcinoma (HCC) is one of the most common malignancies in
the world. The N7-methylguanosine (m7G) modification is related to the biological …

Despite great advances in the treatment of liver hepatocellular carcinoma (LIHC), such as
immunotherapy, the prognosis remains extremely poor, and there is an urgent need to …

The relationship between m6A-related lncRNAs and prognosis in hepatocellular carcinoma
(HCC) is not yet clear. We used Lasso regression to establish a prognostic signature based …

Abstract LncRNA N6-methylandenosine (m6A) modification has been shown to be
associated with the constitution of the tumor microenvironment (TME) and tumorigenesis. It's …

Hepatocellular carcinoma (HCC) is a highly invasive malignancy prone to recurrence, and
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …

5-Methyladenosine (m5C) is a type of epigenetic modification involved in the progression of
various cancers. To investigate the role of m5C-related long non-coding RNAs (lncRNAs) in …

Background To investigate the prognostic significance of N7-methylguanosine (m7G)
regulators and immune infiltration in liver hepatocellular carcinoma (LIHC). Methods The …

Hepatocellular carcinoma (HCC) is one of the most malignant tumors with a poor prognosis.
The long non-coding RNA (lncRNA) has been found to have great potential as a prognostic …